The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Hydroxy-N-[(2,3,5,6-(tetrafluoro)biphenyl-4-yl)]-1,2,5-oxadiazole-3-carboxamide ID: ALA1946659
Cas Number: 1364791-93-4
PubChem CID: 57381314
Max Phase: Preclinical
Molecular Formula: C15H7F4N3O3
Molecular Weight: 353.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1c(F)c(F)c(-c2ccccc2)c(F)c1F)c1nonc1O
Standard InChI: InChI=1S/C15H7F4N3O3/c16-8-7(6-4-2-1-3-5-6)9(17)11(19)12(10(8)18)20-14(23)13-15(24)22-25-21-13/h1-5H,(H,20,23)(H,22,24)
Standard InChI Key: AMBZERWHSFYQLK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-1.8431 -10.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8443 -11.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1294 -11.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4130 -11.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4159 -10.5797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1312 -10.1705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5591 -11.8226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2732 -11.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9880 -11.8212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2725 -10.5845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7623 -11.5352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2703 -12.1853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8089 -12.8693 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0159 -12.6418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9879 -10.7416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5577 -10.1710 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.1296 -12.6485 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.3021 -11.8216 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.1337 -9.3455 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.2940 -10.1658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0103 -10.5773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7227 -10.1628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7201 -9.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9990 -8.9273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2896 -9.3442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 2 0
2 7 1 0
11 15 1 0
3 4 2 0
1 16 1 0
7 8 1 0
3 17 1 0
4 18 1 0
8 9 1 0
6 19 1 0
4 5 1 0
8 10 2 0
20 21 2 0
9 11 1 0
21 22 1 0
2 3 1 0
22 23 2 0
5 6 2 0
23 24 1 0
6 1 1 0
24 25 2 0
25 20 1 0
5 20 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.23Molecular Weight (Monoisotopic): 353.0424AlogP: 3.25#Rotatable Bonds: 3Polar Surface Area: 88.25Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.37CX Basic pKa: ┄CX LogP: 3.55CX LogD: 1.69Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.56Np Likeness Score: -1.10
References 1. Lolli ML, Giorgis M, Tosco P, Foti A, Fruttero R, Gasco A.. (2012) New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold., 49 [PMID:22245049 ] [10.1016/j.ejmech.2011.12.038 ] 2. Sainas S, Pippione AC, Giorgis M, Lupino E, Goyal P, Ramondetti C, Buccinnà B, Piccinini M, Braga RC, Andrade CH, Andersson M, Moritzer AC, Friemann R, Mensa S, Al-Kadaraghi S, Boschi D, Lolli ML.. (2017) Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds., 129 [PMID:28235702 ] [10.1016/j.ejmech.2017.02.017 ]